McKesson Market Cap 2006-2018 | MCK
McKesson market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. McKesson market cap as of April 24, 2019 is $22.1B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $22.098B | $208.357B |
| McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by their ICARE shared principles, their employees work every day to innovate and deliver opportunities that make their customers and partners more successful - all for the better health of patients. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Becton Dickinson (BDX) | United States | $61.357B | 20.38 |
| Align Technology (ALGN) | United States | $23.685B | 60.30 |
| AmerisourceBergen (ABC) | United States | $15.500B | 11.24 |
| Laboratory Of America Holdings (LH) | United States | $14.929B | 13.73 |
| Cooper (COO) | United States | $14.158B | 24.70 |
| Cardinal Health (CAH) | United States | $13.733B | 9.25 |
| DENTSPLY SIRONA (XRAY) | United States | $11.134B | 24.76 |
| Henry Schein (HSIC) | United States | $9.456B | 15.28 |
| West Pharmaceutical Services (WST) | United States | $8.495B | 41.00 |
| Merit Medical Systems (MMSI) | United States | $3.255B | 33.83 |
| CONMED (CNMD) | United States | $2.280B | 37.05 |
| Patterson (PDCO) | United States | $2.051B | 16.20 |
| Atrion (ATRI) | United States | $1.614B | 47.36 |
| STAAR Surgical (STAA) | United States | $1.363B | 114.18 |
| Antares Pharma (ATRS) | United States | $0.453B | 0.00 |
| Invacare (IVC) | United States | $0.244B | 0.00 |
| Lifevantage (LFVN) | United States | $0.171B | 23.02 |
| Pro-Dex (PDEX) | United States | $0.066B | 30.13 |
| Endologix (ELGX) | United States | $0.063B | 0.00 |
| Biolase (BIOL) | United States | $0.047B | 0.00 |
| Retractable Technologies (RVP) | United States | $0.023B | 0.00 |
| Milestone Scientific (MLSS) | United States | $0.017B | 0.00 |
